High glucose and palmitate increases bone morphogenic protein 4 expression in human endothelial cells

Korean Journal of Physiology and Pharmacology

Volumn 20, Issue 2, 2016, Pages 169-175

  Hong, Oak Kee ^a   Yoo, Soon Jib ^a,b   Son, Jang Won ^a,b   Kim, Mee Kyoung ^a,c   Baek, Ki Hyun ^a,c   Song, Ki Ho ^a,c   Cha, Bong Yun ^a,d   Jo, Hanjoong ^e   Kwon, Hyuk Sang ^a,c  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Bone morphogenic protein 4; Diabetes mellitus; Free fatty acid; High glucose

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CELL ADHESION MOLECULE; GLUCOSE; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; LOSS OF FUNCTION MUTATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84959867643     PISSN: 12264512     EISSN: 20933827     Source Type: Journal    
DOI: 10.4196/kjpp.2016.20.2.169     Document Type: Article

References (28)

1. Wong WT, Tian XY, Chen Y, Leung F.P., Liu L., Lee HK, Ng CF, Xu A, Yao X., Vanhoutte PM, Tipoe GL, Huang Y. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension. Circ Res. 2010; 107:984-991.
2. Cai J, Pardali E, Sánchez-Duffhues G, ten Dijke P. BMP signaling in vascular diseases. FEBS Lett. 2012; 586:1993-2002.
3. Maciel TT, Kempf H, Campos AH Targeting bone morphogenetic protein signaling on renal and vascular diseases. Curr Opin Nephrol Hypertens. 2010; 19:26-31.
4. Boström K.I., Jumabay M, Matveyenko A., Nicholas SB, Yao Y. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res. 2011; 108:446-457.
5. Csiszar A, Labinskyy N, Smith K.E., Rivera A., Bakker EN, Jo H, Gardner J, Orosz Z., Ungvari Z. Downregulation of bone morpho-genetic protein 4 expression in coronary arterial endothelial cells: role of shear stress and the cAMP/protein kinase A pathway. Arterioscler Thromb Vasc Biol. 2007; 27:776-782.
6. Sorescu GP, Song H, Tressel S.L., Hwang J., Dikalov S, Smith DA, Boyd N.L., Platt MO, Lassègue B, Griendling K.K., Jo H. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res. 2004; 95:773-779.
7. Koga M, Engberding N, Dikalova A.E., Chang KH, Seidel-Rogol B, Long JS, Lassègue B, Jo H., Griendling KK. The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice. Am J Physiol Heart Circ Physiol. 2013; 305:H747-755.
8. Jo H, Song H, Mowbray A. Role of NADPH oxidases in disturbed flow- and BMP4-induced inflammation and atherosclerosis. Antioxid Redox Signal. 2006; 8:1609-1619.
9. Csiszar A, Lehoux S, Ungvari Z. Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxid Redox Signal. 2009; 11:1683-1697.
10. Csiszar A, Labinskyy N, Jo H., Ballabh P, Ungvari Z. Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells. Am J Physiol Heart Circ Physiol. 2008; 295:H569-577.
11. Jaimes EA, Hua P, Tian R.X., Raij L. Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol. 2010; 298:F125-132.
12. Chinen I, Shimabukuro M, Yamakawa K., Higa N, Matsuzaki T, Noguchi K, Ueda S., Sakanashi M, Takasu N. Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology. 2007; 148:160-165.
13. Hou Q, Lei M, Hu K., Wang M. The effects of high glucose levels on reactive oxygen species-induced apoptosis and involved signaling in human vascular endothelial cells. Cardiovasc Toxicol. 2015; 15:140-146.
14. Hu J, Liu J, Kwok M.W., Wong RH, Huang Y, Wan S. Bone morphogenic protein-4 contributes to venous endothelial dysfunction in patients with diabetes undergoing coronary revascularization. Ann Thorac Surg. 2013; 95:1331-1339.
15. Zhang Y, Liu J, Tian X.Y., Wong WT, Chen Y, Wang L, Luo J., Cheang WS, Lau CW, Kwan KM, Wang N, Yao X., Huang Y. Inhibition of bone morphogenic protein 4 restores endothelial function in db/db diabetic mice. Arterioscler Thromb Vasc Biol. 2014; 34:152-159.
16. Du X, Edelstein D, Obici S., Higham N, Zou MH, Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest. 2006; 116:1071-1080.
17. Son JW, Jang EH, Kim M.K., Baek KH, Song KH, Yoon KH, Cha B.Y., Son HY, Lee KW, Jo H, Kwon HS Serum BMP-4 levels in relation to arterial stiffness and carotid atherosclerosis in patients with Type 2 diabetes. Biomark Med. 2011; 5:827-835.
18. Zhu P, Chen G, You T., Yao J, Jiang Q, Lin X., Shen X, Qiao Y, Lin L. High FFA-induced proliferation and apoptosis in human umbilical vein endothelial cell partly through Wnt/beta-catenin signal pathway. Mol Cell Biochem. 2010; 338:123-131.
19. Inoguchi T, Li P, Umeda F., Yu HY, Kakimoto M, Imamura M, Aoki T., Etoh T, Hashimoto T, Naruse M., Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000; 49:1939-1945.
20. Upton PD, Long L, Trembath R.C., Morrell NW. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells. Mol Pharmacol. 2008; 73:539-552.
21. Wu J, Yu Z, Su D. BMP4 protects rat pulmonary arterial smooth muscle cells from apoptosis by PI3K/AKT/Smad1/5/8 signaling. Int J Mol Sci. 2014; 15:13738-13754.
22. Zhang M, Zhou SH, Zhao S, Li X P, Liu LP, Shen XQ Pioglitazone can downregulate bone morphogenetic protein-2 expression induced by high glucose in human umbilical vein endothelial cells. Pharmacology. 2008; 81:312-316.
23. Csiszar A, Ahmad M, Smith K.E., Labinskyy N., Gao Q, Kaley G, Edwards J.G., Wolin MS, Ungvari Z. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. Am J Pathol. 2006; 168:629-638.
24. Kim CW, Song H, Kumar S., Nam D, Kwon HS, Chang K.H., Son DJ, Kang DW, Brodie SA, Weiss D, Vega J.D., Alberts-Grill N, Griendling K, Taylor W.R., Jo H. Anti-inflammatory and antiatherogenic role of BMP receptor II in endothelial cells. Arterioscler Thromb Vasc Biol. 2013; 33:1350-1359.
25. Chung JH, Jeon HJ, Hong S.Y., Lee da L, Lee KH, Kim S.H., Han YS, Manabe I, Miller YI, Lee SH Palmitate promotes the paracrine effects of macrophages on vascular smooth muscle cells: the role of bone morphogenetic proteins. PLoS One. 2012; 7:e29100.
26. Maloney E, Sweet IR, Hockenbery D.M., Pham M., Rizzo NO, Tateya S, Handa P, Schwartz M.W., Kim F. Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol. 2009; 29:1370-1375.
27. Cybulsky MI, Iiyama K, Li H., Zhu S, Chen M, Iiyama M., Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest. 2001; 107:1255-1262.
28. Xu S, He Y, Vokurkova M., Touyz RM. Endothelial cells negatively modulate reactive oxygen species generation in vascular smooth muscle cells: role of thioredoxin. Hypertension. 2009; 54:427-433.